• Explore /
  • Poster
  • / SPARK, studying pathways of resistance in KRAS-driven cancers: A remote plasma ctDNA participation study to identify mechanisms of resistance to KRAS inhibitors.

SPARK, studying pathways of resistance in KRAS-driven cancers: A remote plasma ctDNA participation study to identify mechanisms of resistance to KRAS inhibitors.

Abstract Poster

Authors

null

Biagio Ricciuti

Dana-Farber Cancer Institute, Lowe Center for Thoracic Oncology, Boston, MA

Biagio Ricciuti , Elinton Lee , Terri Conneran , Jennifer C. King , Allison Harper , Giuseppe Lamberti , Gifty Brisbane , Katerina Hoskova , Sarah Clifford , Jo-Ellen Murphy , Richard S.P. Huang , Geoffrey R. Oxnard , Anthony Addario , Richard M. Erwin , Khaled Tolba , Mark M. Awad

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Small Molecules

Clinical Trial Registration Number

NCT05272423

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS3166)

DOI

10.1200/JCO.2023.41.16_suppl.TPS3166

Abstract #

TPS3166

Poster Bd #

357b

Abstract Disclosures

Similar Posters

First Author: Tariq Arshad

First Author: Ramaswamy Govindan

First Author: Celine Yeh

Poster

2024 ASCO Gastrointestinal Cancers Symposium

<span>Association of candidate alterations with primary resistance to </span><em>KRAS G12D </em><span>targeting in colorectal cancer.</span>

Association of candidate alterations with primary resistance to KRAS G12D targeting in colorectal cancer.

First Author: Khalid Jazieh